These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11726421)

  • 1. A dose-determining trial of heparinase-I (Neutralase) for heparin neutralization in coronary artery surgery.
    Heres EK; Horrow JC; Gravlee GP; Tardiff BE; Luber J; Schneider J; Barragry T; Broughton R
    Anesth Analg; 2001 Dec; 93(6):1446-52, table of contents. PubMed ID: 11726421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralase reverses the anti-coagulant but not the anti-thrombotic activity of heparin in a rabbit model of venous thrombosis.
    Silver PJ; Broughton R; Bouthillier J; Quinn TA; Wallace AM; Weishaar RE
    Thromb Res; 1998 Aug; 91(3):143-50. PubMed ID: 9733158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of heparinase I versus protamine in patients undergoing coronary artery bypass grafting with and without cardiopulmonary bypass.
    Stafford-Smith M; Lefrak EA; Qazi AG; Welsby IJ; Barber L; Hoeft A; Dorenbaum A; Mathias J; Rochon JJ; Newman MF;
    Anesthesiology; 2005 Aug; 103(2):229-40. PubMed ID: 16052104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparinase I (neutralase) reversal of systemic anticoagulation.
    Michelsen LG; Kikura M; Levy JH; Lee MK; Lee KC; Zimmermann JJ; Szlam F
    Anesthesiology; 1996 Aug; 85(2):339-46. PubMed ID: 8712450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
    Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
    Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparinase thromboelastography compared with activated coagulation time for protamine titration after cardiopulmonary bypass.
    Levin AI; Heine AM; Coetzee JF; Coetzee A
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):224-9. PubMed ID: 24461364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of heparinase 1 and protamine on platelet reactivity.
    Ammar T; Fisher CF
    Anesthesiology; 1997 Jun; 86(6):1382-6. PubMed ID: 9197309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin neutralization by recombinant platelet factor 4 and protamine.
    Levy JH; Cormack JG; Morales A
    Anesth Analg; 1995 Jul; 81(1):35-7. PubMed ID: 7598278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial.
    Meesters MI; Veerhoek D; de Lange F; de Vries JW; de Jong JR; Romijn JW; Kelchtermans H; Huskens D; van der Steeg R; Thomas PW; Burtman DT; van Barneveld LJ; Vonk AB; Boer C
    Thromb Haemost; 2016 Aug; 116(2):251-61. PubMed ID: 27277211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin Reversal After Cardiopulmonary Bypass: Are Point-of-Care Coagulation Tests Interchangeable?
    Willems A; Savan V; Faraoni D; De Ville A; Rozen L; Demulder A; Van der Linden P
    J Cardiothorac Vasc Anesth; 2016 Oct; 30(5):1184-9. PubMed ID: 27461795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of protamine dose on activated clotting time and thromboelastography in infants and small children undergoing cardiopulmonary bypass.
    Gautam NK; Schmitz ML; Harrison D; Zabala LM; Killebrew P; Belcher RH; Prodhan P; McKamie W; Norvell DC
    Paediatr Anaesth; 2013 Mar; 23(3):233-41. PubMed ID: 23279140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of thromboelastography with heparinase or protamine sulfate added in vitro during heparinized cardiopulmonary bypass.
    Spiess BD; Wall MH; Gillies BS; Fitch JC; Soltow LO; Chandler WL
    Thromb Haemost; 1997 Aug; 78(2):820-6. PubMed ID: 9268178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery.
    Yamamoto T; Wolf HG; Sinzobahamvya N; Asfour B; Hraska V; Schindler E
    Thorac Cardiovasc Surg; 2015 Aug; 63(5):397-403. PubMed ID: 26121380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiopulmonary bypass and blood coagulation].
    Kitaguchi K; Furuie H
    Masui; 2001 Dec; 50 Suppl():S115-20. PubMed ID: 11871083
    [No Abstract]   [Full Text] [Related]  

  • 15. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
    Vonk AB; Veerhoek D; van den Brom CE; van Barneveld LJ; Boer C
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass.
    Mochizuki T; Olson PJ; Szlam F; Ramsay JG; Levy JH
    Anesth Analg; 1998 Oct; 87(4):781-5. PubMed ID: 9768770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the effect of varying protamine-to-heparin ratio on coagulation in vitro.
    Ho LTS; McVey MJ; Kuiper GJAJM; Gross PL; Karkouti K
    Br J Anaesth; 2021 Oct; 127(4):e128-e130. PubMed ID: 34334192
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison between arterial- and venous-sampled activated clotting time measurements.
    Zisman E; Rozenberg B; Katz Y; Ziser A
    Isr J Med Sci; 1997 Dec; 33(12):786-8. PubMed ID: 9464347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin anticoagulation in patients undergoing off-pump and on-pump coronary bypass surgery.
    Tanaka KA; Thourani VH; Williams WH; Duke PG; Levy JH; Guyton RA; Puskas JD
    J Anesth; 2007; 21(3):297-303. PubMed ID: 17680178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated protamine dose assay in heparin reversal management after cardiopulmonary by pass.
    Guarracino F; De Cosmo D; Penzo D; Tedesco M; Bossi A; Zussa C; Polesel E; De Stefani R
    Minerva Anestesiol; 2001 Apr; 67(4):165-9. PubMed ID: 11376504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.